A pilot trial of consolidation bevacizumab after hypo‐fractionated concurrent chemoradiotherapy in patients with unresectable locally advanced non‐squamous non‐small‐cell lung cancer

PURPOSE: To determine the feasibility of incorporating bevacizumab consolidation into hypo‐fractionated concurrent chemoradiotherapy (hypo‐CCRT) for patients with unresectable locally advanced non‐squamous non‐small‐cell lung cancer (LA‐NS‐NSCLC). PATIENTS AND METHODS: Eligible patients were treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, LanQing, Chu, Chu, Jiang, XiaoBo, Zheng, ShiYang, Zhang, PengXin, Zhou, Rui, Chen, NaiBin, Guo, JinYu, Qiu, Bo, Liu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523965/
https://www.ncbi.nlm.nih.gov/pubmed/37537968
http://dx.doi.org/10.1002/cam4.6381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523965/
https://www.ncbi.nlm.nih.gov/pubmed/37537968
http://dx.doi.org/10.1002/cam4.6381

Ejemplares similares